Clinical effect of platelet-rich plasma in orthopedics and its influencing factors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031299

Enrollment

Unknown

Registered

2020-03-27

Start date

2019-12-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, external humeral epicondylitis, plantar fasciitis and other orthopedic diseases

Interventions

Observation group:PRP injection therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Joint degeneration and osteoarthritis (cartilage repairable stage); 2. External humeral epicondylitis; 3. Patellar tendon disease; 4. Rotator cuff partially torn; 5. Plantar fasciitis; 6. Delayed union and nonunion of fractures.

Exclusion criteria

Exclusion criteria: 1. Have an active infection; 2. Use anticoagulants, or antiplatelet agents; 3. Cachexia; 4. A malignant tumor; 5. Use a systemic immunosuppressant; 6. The patient has low platelet function and number.

Design outcomes

Primary

Measure	Time frame
BR;Blood coagulation function;ESR;CRP;Pain visual score;	—

Countries

China

Contacts

Public ContactYin Ke

The First Affiliated Hospital of Nanhua University

357520637@qq.com+86 18973405240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026